2019 annual financial data
Outlook Therapeutics 2019 Operating margin
Outlook Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -445.61%.
Operating income was -36,299,000 USD and net income was -34,524,000 USD.
Operating cash flow was Not available.
Get free Outlook Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,146,000 USD
- Operating income
- -36,299,000 USD
- Net income
- -34,524,000 USD
- Operating cash flow
- Not available